Polymer Compound, Compositions Using It, and Medical Devices
This patent introduces novel polymer compounds designed to significantly enhance the biocompatibility of medical devices. By multi-laterally inhibiting coa…
Next-Gen Biocompatible Polymers: Reduce Complications by ~20%
~$650K/year estimated medical cost reduction per facility (est.)
Fruit Tree, Fruit Tree Pruning Method, and Fruit Production Method
This technology introduces a novel pruning method that optimizes fruit tree branch structures to maximize sunlight exposure and nutrient delivery. It incre…
Boost Fruit Weight by 15%, Improve Harvest Efficiency by 20%
~$75K/year estimated revenue increase and cost reduction per facility (est.)
Cultivation Shelf, System, and Method for Fruit and Vegetable Crops
This technology introduces an innovative cultivation shelf and method for fruit and vegetable crops, drastically reducing manual trellising labor by up to …
80% Less Labor, 1.5x Yield in Fruit & Vegetable Cultivation
~$150K/year estimated trellising cost reduction per facility (est.)
Method for Isolating Cell Membranes from Animal Cells, and Isolated Cell Membrane
This technology offers a simple, high-purity method for isolating animal cell membranes, bypassing complex traditional techniques. By minimizing cellular d…
Cell Membrane Isolation: ~30% Faster Bio-Development, High Purity
~$550K/year estimated R&D cost reduction per facility (AI est.)
Cell Separation Method for Isolating Cells from Solution, and Hydratable Composition for…
This technology offers a novel, simple method for high-purity cell separation using a specially formulated hydratable composition. By precisely controlling…
Cell Separation: ~40% R&D Cost Reduction, High Purity & Viability
~$250K/year estimated research cost reduction per facility (est.)
Sterilization Method Using Pulsed Plasma and Sterilized Objects
This technology offers a novel pulsed plasma sterilization method for packaged items, including food and medical products, without requiring package openin…
Pulsed Plasma Sterilization: ~20% Production Efficiency Boost, Zero Package Damage
~$80,000/year estimated cost savings per facility (est.)
Ultrasonic Image Search Device and Program
This AI-driven system revolutionizes cardiac echo examinations by automatically identifying optimal probe positions and extracting diagnostic-quality image…
AI-driven Ultrasound: 20% Faster Cardiac Echo, Consistent Accuracy
~$200K/year estimated examination cost savings per facility (est.)
Agent for Inhibiting Invasive Metastasis of Pancreatic Cancer Cells
This technology offers a novel drug to inhibit pancreatic cancer metastasis. It targets mTOR and ERK1/2 signaling pathways, preventing abnormal cell prolif…
Pancreatic Cancer: Dual Inhibition Curbs Metastasis, Potentially Improving Outcomes by ~30%
~$0.7M/year estimated revenue potential (est.)
Pancreatic Cancer Therapeutic Agent
This technology combines existing drugs, sirolimus with gemcitabine or TS-1, to create a synergistic treatment for pancreatic cancer. It aims to significan…
Pancreatic Cancer: Dual-Drug Therapy Doubles Response Rate, Extends Survival
~$150M–$600M/year estimated economic impact per major licensee (est.)
Display Control Device and Display Control Program
This technology uses motion sensors on impaired limbs to project a virtual limb with amplified distal movement. This creates a powerful sense of body owner…
VR Rehab Revolution: Enhance Body Sensation by 1.5x for Faster Recovery
~$1M/year estimated economic impact per facility due to 20% improved rehab efficiency (AI est.).
Electrochemical Label-Free Nucleic Acid Detection Method
This technology offers a novel label-free electrochemical method for highly sensitive nucleic acid detection. By eliminating costly labeling reagents and c…
Label-Free Nucleic Acid Detection: ~33% Cost & Labor Reduction
~$150K/year estimated cost reduction per facility (est.)
Pressure Detection Device
This technology dramatically enhances piezoelectric sensor sensitivity through a unique mechanical design, precisely controlling the central and edge movem…
3x Sensitivity, Capturing Micro-Pressures for Enhanced Precision
~$150K/year estimated cost reduction per facility (est.)
Method for Producing Gelatinized Starch Powder
This technology precisely controls twin-screw extruders for gelatinized starch powder production using a unique 'QE value' (400+). It ensures uniform, high…
QE Value Control Boosts Starch Powder Output by 2×, Cuts Costs 20%
~$250K/year estimated cost savings per facility (est.).
Biological Information Detection Device
This technology precisely detects biological information by uniquely eliminating noise from body surface potential and static electricity. It ensures stabl…
2x Accuracy, 80% Fewer False Alarms in Biosignal Monitoring
~$50K/year estimated cost savings per facility (est.)
Recrystallization Method, Starch Material Containing Recrystallized Starch, and Food and…
This technology recrystallizes low-crystallinity starch using only heat, eliminating energy-intensive cooling. It enhances starch properties, improving foo…
Heat-Only Starch Recrystallization: ~30% Cost Savings, Enhanced Food Stability
~$200K/year estimated cost reduction per facility (est.)
Discrimination Device, Discrimination Terminal Device, Control Method and Program for Di…
This technology provides an AI-powered discrimination device for highly accurate and efficient oral tumor detection. It integrates expert medical knowledge…
AI-Powered Oral Tumor Detection: >95% Accuracy, Accelerating Diagnosis
~$1M–$10M/year estimated economic impact per facility (est.)
Harvesting Robot, Control Method and Control Program for Harvesting Robot, and Harvestin…
This innovative robot system automates the harvesting of crops from deciduous trees. It combines pre-stored 3D environmental data with real-time sensor inp…
Automated Harvesting: Cut Collisions 20%, Boost Yields 10%
~$150K/year estimated cost reduction per facility (est.)
Sensor for Evaluating Swallowing Movements
This technology is a highly sensitive, non-invasive sensor that continuously monitors swallowing movements by detecting subtle laryngeal changes via a resi…
Continuous Swallowing Monitoring: Boosts Evaluation Efficiency by 20%
~$10.0M/year estimated healthcare and elder care cost reduction (est.)
Epidural Anesthesia Support System, Epidural Anesthesia Training Method, and Display Dev…
This AR-powered goggle system overlays real-time spinal anatomy onto a patient or model, guiding epidural procedures. It dramatically enhances puncture acc…
AR-Guided Epidural: Boost Puncture Accuracy by 90%, Cut Risks
~$250K/year estimated economic benefit per facility (est.)
Method for Predicting Onset Risk of Diseases with TDP-43 Aggregate Accumulation, Diagnos…
This technology offers a groundbreaking method to predict the onset risk of neurodegenerative diseases (e.g., ALS, FTLD) linked to TDP-43 aggregates. By de…
Early TDP-43 Risk Prediction: Accelerates Drug Development by ~30%
~$65M/year estimated new market creation (est.)
Bending and Extension Device and Method
This technology features a hollow elastic guide and two flexible strips that slide relative to each other, enabling precise bending and extension from any …
1.5× Productivity, ~$16.5M Annual Cost Reduction in Precision Robotics
~$16.5M/year estimated cost reduction and 1.5x productivity increase per facility (est.).
Spinal Cord Tissue-Targeting Peptide and Its Applications
This technology offers a novel peptide for highly efficient, targeted drug delivery to spinal cord tissues. It overcomes limitations of systemic administra…
Targeted Spinal Drug Delivery: ~20% Drug Reduction, Faster Recovery
~$1.0M/year estimated healthcare cost reduction and treatment duration shortening per facility (est.…
Malignant Glioma Molecular-Targeting Peptide
This technology provides molecular-targeting peptides (NTGSPYE or RGATPMS) that cross the blood-brain barrier (BBB) and selectively deliver drugs to malign…
Glioma Therapy Breakthrough: Peptide Boosts Brain Drug Delivery by ~20%
~$3.5M/year estimated new revenue potential per adopting company (est.)
Pharmaceutical for the Prevention or Treatment of Hypertension
This technology introduces a novel pharmaceutical for hypertension prevention and treatment, utilizing Dipeptidyl Peptidase III (DPPIII) protein. It offers…
Novel DPPIII Target: Hypertension Treatment with ~$450M Annual Impact
~$450M/year estimated healthcare economic benefit (est.)